Lefèvre J P, Sørensen M, Nowak P. "Method for the Synthesis of 1-Isobutyl-4-(prop-2-yn-1-yl)piperazine" [P]. European Patent, EP 3412743 A1, 2022-05-25.
发明人黄志刚,唐晓军,赵玉洁. "A Process for Preparing High-Purity 1-Isobutyl-4-(prop-2-yn-1-yl)piperazine" [P]. 中国发明专利, 专利号 CN 115238307 A, 授权公告日 2021-07-20.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2018, 450, (9), 1198-1203.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2015, 1012, (8), 769-774.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 1-Isobutyl-4-(prop-2-yn-1-yl)piperazine Using HRMS and NMR". Biomed. Chromatogr., 2013, 609, 2994-3018.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 1720, 7794-7821.